Federal contract award
W911SR22C0049
DEVELOPMENT OF NEW FEATURES TO PSET DATA SYSTEM
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG |
| NAICS | 334614 |
| PSC | DA01 — Support services for activities involved with application development and support to include analysis, design, development, coding, testing, and release packaging, as well as support of off-the-shelf Business Applications. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.1M |
| Current contract value | $3.5M |
| Potential contract value / ceiling | $3.5M |
| Start date | Sep 21, 2022 |
| Current end date | Sep 21, 2027 |
| Potential end date | Sep 21, 2027 |
| Latest award activity | May 15, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 15, 2026 | P00010 | $0 | DEVELOPMENT OF NEW FEATURES, SUSTAINMENT AND TECHNOLOGY TRANSITION OF BIOINFORMATICS SOFTWARE ANALYSIS TOOL POLYMERASE CHAIN REACTION (PCR) SIGNATURE EROSION TOOL (PSET). |
| Mar 5, 2026 | P00009 | $391.5K | DEVELOPMENT, SUSTAINMENT, TRANSITION OF POLYMERASE CHAIN REACTION (PCR) SIGNATURE EROSION TOOL (PSET), A BIOINFORMATICS SOFTWARE SYSTEM USED BY THE DBPAO TO MONITOR, UPDATE MOLECULAR DIAGNOSTIC ASSAYS FOR EMERGING BIOLOGICAL THREATS. |
| Jul 29, 2025 | P00008 | $201.1K | THIS MODIFICATION IS TO ADD ADDITIONAL FUNDING TO CLIN 3000 IN THE AMOUNT OF $75,651.00. |
| Jul 16, 2025 | P00007 | $75.7K | THIS MODIFICATION IS TO ADD ADDITIONAL FUNDING TO CLIN 3000 IN THE AMOUNT OF $75,651.00. |
| Apr 14, 2025 | P00006 | $0 | DEVELOPMENT OF NEW FEATURES, SUSTAINMENT, AND TECHNOLOGY TRANSITION OF BIOINFORMATICS SOFTWARE ANALYSIS TOOL POLYMERASE CHAIN REACTION SIGNATURE EROSION TOOL (PSET). |
| Sep 11, 2024 | P00005 | $0 | DEVELOPMENT OF NEW FEATURES, SUSTAINMENT AND TECHNOLOGY TRANSITION OF BIOINFORMATICS SOFTWARE ANALYSIS TOOL POLYMERASE CHAIN REACTION (PCR) SIGNATURE EROSION TOOL (PSET). |
| Aug 16, 2024 | P00004 | $197.5K | DEVELOPMENT OF NEW FEATURES, SUSTAINMENT AND TECHNOLOGY TRANSITION OF BIOINFORMATICS SOFTWARE ANALYSIS TOOL POLYMERASE CHAIN REACTION (PCR) SIGNATURE EROSION TOOL (PSET) |
| Jan 17, 2024 | P00003 | $68.2K | DEVELOPMENT OF NEW FEATURES, SUSTAINMENT AND TECHNOLOGY TRANSITION OF BIOINFORMATICS SOFTWARE ANALYSIS TOOL POLYMERASE CHAIN REACTION (PCR) SIGNATURE EROSION TOOL (PSET) |
| Jul 31, 2023 | P00002 | $272.6K | DEVELOPMENT OF NEW FEATURES TO PSET |
| May 11, 2023 | P00001 | $150.4K | DEVELOPMENT OF NEW FEATURES TO PSET |
| Sep 21, 2022 | 0 | $546.3K | DEVELOPMENT OF NEW FEATURES TO PSET DATA SYSTEM |
Estimated positioning window
Nov 1, 2026 – Mar 21, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-09-21 (324 days from calculation)
- +35 points
- 1 historical awards in this buyer and category group
- +0 points
- 11 recorded award transactions
- +10 points
- Latest award action: 2026-05-15
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.